Kalvista Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-10-31 | 2024-07-31 | 2024-04-30 | 2024-01-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $1,206 | $0 |
Gross Profit | -224 | 987 | -207 | |
EBITDA | -45,584 | -43,991 | -44,431 | -32,944 |
EBIT | -45,811 | -44,215 | -44,650 | -33,151 |
Net Income | -42,268 | -40,443 | -44,650 | -29,028 |
Net Change In Cash | 0 | 0 | 1,206 | 0 |
Free Cash Flow | -39,844 | -40,241 | -15,521 | -27,590 |
Cash | 41,581 | 31,848 | 31,789 | 23,056 |
Basic Shares | 46,695 | 46,232 | 43,590 | 34,723 |
Annual Financials
| Values in thousands | 2024-04-30 | 2023-04-30 | 2022-04-30 | 2021-04-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $12,690 |
Gross Profit | -86,167 | -802 | -743 | 12,039 |
EBITDA | -134,280 | -92,105 | -81,596 | -45,593 |
EBIT | -135,096 | -92,907 | -82,339 | -46,244 |
Net Income | -126,644 | -74,853 | -68,512 | -44,494 |
Net Change In Cash | 0 | 0 | 0 | 12,690 |
Cost of Revenue | 24,270 | -18,693 | 34,292 | |
Free Cash Flow | -89,674 | -76,457 | -79,065 | -30,253 |
Cash | 31,789 | 56,238 | 30,732 | 50,592 |
Basic Shares | 36,786 | 27,890 | 24,473 | 19,094 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-10-31 | -$0.91 |
2024-07-31 | -$0.87 |
2024-04-30 | -$1.02 |
2024-01-31 | -$0.84 |
